🔬 Wits PhD Candidate Bontle Masango Embarks on Global Diabetes Research Journey

Bontle Masango, a dedicated PhD candidate at the University of the Witwatersrand's (Wits) School of Clinical Medicine in South Africa, has taken a significant step forward in her career by securing a prestigious 2025/2026 Fulbright Scholarship. This award allows her to spend five months at the renowned Broad Institute of MIT and Harvard, a powerhouse in genomics and biomedical research. Her focus? Advancing studies on type 2 diabetes mellitus (T2DM), the most prevalent form of diabetes in Africa, through cutting-edge genomic analysis tailored to African populations.

Masango's move highlights the growing international recognition of South African higher education talent. As a researcher from Wits, one of Africa's top universities, she exemplifies how South African institutions are nurturing the next generation of global scientists. Her work addresses a critical public health challenge, bridging local insights with world-class resources.

The Alarming Rise of Type 2 Diabetes in South Africa

Type 2 diabetes, characterized by insulin resistance and relative insulin deficiency leading to elevated blood glucose levels, affects millions in South Africa. According to recent data, approximately 7.2% of adults aged 20-79—equating to over 2.3 million people—live with diabetes, making South Africa one of the highest-prevalence countries in Africa. Alarmingly, more than 50% of cases in Africa go undiagnosed until complications such as cardiovascular disease, chronic kidney disease, retinopathy leading to blindness, and peripheral neuropathy resulting in amputations manifest.

In South Africa, urbanization, dietary shifts toward processed foods high in refined sugars and unhealthy fats, sedentary lifestyles, and genetic predispositions exacerbate the epidemic. The incidence rate stands at around 14.6 cases per 1,000 person-years among middle-aged adults, with South Africa reporting the highest rates in certain cohorts. This burden strains the National Health Insurance (NHI) system and underscores the need for precision medicine approaches that account for African-specific genetic and environmental factors.

For those exploring careers in health sciences, opportunities abound at institutions like Wits through research jobs focused on non-communicable diseases.

Masango's Research Roots: From Master's to PhD at Wits University

Masango's journey began with her master's in genomic medicine at Wits, where she examined postprandial glucose (PPG) responses—how blood sugar levels fluctuate after meals—in South African adults. This laid the foundation for her PhD, which delves into genomic variations influencing diabetes risk. By integrating DNA analysis with lifestyle data, she aims to pinpoint early biomarkers.

Under supervision at Wits' Sydney and Bridgette Ratcliffe Laboratories, Masango's work emphasizes underrepresented African ancestries. Current European-centric tools often fail here, as genetic risk scores perform poorly across diverse populations. Her research promises to customize interventions, such as personalized dietary advice based on genomic profiles.

Key Insights from Masango's Landmark Publication on PPG Variability

In a pivotal 2024 study published in a peer-reviewed journal, Masango led research on PPG variability in 794 South Africans of African ancestry from the Birth to Twenty Plus cohort. Using principal component analysis (PCA), they clustered sex hormones, liver enzymes (like alanine aminotransferase or ALT), and cardiometabolic factors (e.g., lipids, body fat distribution).

Findings revealed that these clusters explain about 10.6% of PPG variance in men (driven by peripheral fat, liver enzymes/steroid hormones, lipids) and 10.8% in women (central fat, lipids/liver enzymes). Notably, type 2 diabetes polygenic risk scores (PRS)—sums of genetic variants weighted by effect size—did not significantly contribute, highlighting the need for ancestry-specific PRS development.

• PCA1 (men: peripheral fat; women: central fat) strongly linked to PPG excursions.
• Liver enzymes and steroid hormones (e.g., testosterone, estradiol) modulate responses differently by sex.
• Lipid profiles (triglycerides, HDL) influence post-meal glucose spikes.

This step-by-step process—oral glucose tolerance test (OGTT), area under curve calculation via trapezoidal rule, multivariable regression—provides actionable insights for sex-stratified risk assessment.

Read the full study for deeper methodology: PubMed abstract.

The Fulbright Scholarship: Elevating South African Talent Globally

The Fulbright Foreign Student Program, administered by the U.S. Department of State, selects scholars based on academic excellence, leadership, and impact potential. Masango's award underscores South Africa's higher education prowess, with Wits alumni frequently securing such honors. This exchange fosters bilateral ties, knowledge transfer, and addresses global health inequities.

For aspiring PhD students, Fulbright opens doors to elite labs. Resources like Wits' international office can guide applications. Explore academic CV tips for competitive edges.

Collaborating at the Broad Institute: Genomics Powerhouse

The Broad Institute pioneers diabetes genomics via initiatives like the Diabetes Genetics Initiative and diverse GWAS studies identifying 150+ T2D loci across ancestries. Masango will train in whole-genome sequencing, admixture scans for African Americans (relevant to admixed SA populations), and multi-omics integration.

Her tenure involves cross-disciplinary teams tackling biomedicine challenges, potentially co-authoring papers on African T2D subtypes. Learn more at the Broad Diabetes page.

Addressing Gaps in African Precision Medicine

Most genomic data derives from Europeans, limiting PRS accuracy for Africans (where linkage disequilibrium differs). Masango's work advances 'African-first' approaches, akin to H3Africa consortium efforts. By combining PPG phenotyping with genomics, she paves the way for polygenic scores predicting T2D progression in SA contexts.

Stakeholders—from NHI policymakers to clinicians—stand to benefit, enabling targeted screenings in high-risk townships like Soweto.

Impacts on South African Healthcare and Economy

T2D costs SA billions annually in direct care and lost productivity. Early detection via Masango's models could avert complications, saving lives and resources. Culturally attuned interventions—factoring ubuntu community dynamics and local diets—enhance adherence.

Wits' investment in such research positions it as a hub for research jobs in genomics.

Wits University's Support for Emerging Researchers

Wits fosters talent via scholarships, labs, and global partnerships. Masango credits her supervisors for mentorship. For students, scholarships and professor ratings aid navigation.

Future Prospects: Revolutionizing T2D Management in Africa

Post-Fulbright, Masango plans to return, establishing a Wits-Broad collaboration. Long-term: AI-driven apps for PPG prediction, clinical trials for African PRS-guided therapies. Optimistic outlook amid rising prevalence.

Career Advice for Aspiring Diabetes Researchers in SA

1. Build strong genomics foundations via Wits courses.
2. Publish early, like Masango's PPG paper.
3. Apply for Fulbright; network globally.
4. Seek postdoc positions.
5. Engage communities for translational impact.

Visit postdoc advice.

Conclusion: Spotlight on SA's Rising Stars

Masango's odyssey inspires, proving SA PhDs can shine globally. For jobs, check higher ed jobs, university jobs, or rate your professors. Explore career advice and post your profile today.

Photo by Google DeepMind on Unsplash